Unified Protocol for emotional disorders in prison groups
Official title: Feasibility and Clinical Utility Study of the Unified Protocol for Group Treatment of Emotional Disorders in Penitentiary Facilities
Run by Instituto de Investigación Sanitaria Aragón · NCT07070531 · Data updated 2026-11-12
This study tests the Unified Protocol in group sessions to help inmates with anxiety, depression, and related mood issues.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Instituto de Investigación Sanitaria Aragón Academic / other |
| Locations | 2 sites (Manresa, Catalonia and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07070531 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are incarcerated individuals aged adults with at least one emotional disorder, proficient in Spanish or Catalan, willing to participate in all sessions, and stable on pharmacological treatment if applicable.
✕Probably not a fit
Individuals without an emotional disorder, those with active suicide risk, or those unlikely to complete the program may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will deliver the transdiagnostic Unified Protocol in a group format to incarcerated individuals diagnosed with emotional disorders. The intervention is based on cognitive behavioral therapy techniques and aims to address multiple anxiety and mood symptoms within a single program. Participants will be Spanish- or Catalan-speaking adults in two Catalonia facilities, with eligibility including confirmed emotional disorder, abstinence from substances for over a month, and stable treatment if applicable. Sessions will be conducted in correctional settings, focusing on feasibility, acceptability, and potential symptom improvements. The study leverages existing resources to maximize access to mental health care within prisons.
Why it matters
Potential benefit: If successful, participants could experience reductions in anxiety and depressive symptoms and improved emotion regulation, with group delivery offering a cost-effective approach in prisons.
How similar studies have gone: Previous research supports the effectiveness and group-format efficiency of the Unified Protocol in diverse settings, though its application in correctional facilities is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least one emotional disorder diagnosis (e.g., anxiety, depression, OCD, trauma-related, somatic, dissociative) based on the MINI interview * Comprehension of the intervention language (Spanish or Catalan) * Substance abstinence for more than 1 month * Voluntary participation and availability for all assessment and treatment sessions * Stable pharmacological treatment during the study unless medically contraindicated * Signed informed consent Exclusion Criteria: * No emotional disorder diagnosis * Cognitive impairment or IQ \<70 preventing comprehension * Diagnosis of a mental disorder incompatible with group formats (e.g., histrionic personality disorder) * Suicide risk at assessment * Legal status involving potential release or leave that could affect adherence
Where it's running
-
Althaia Xarxa Assistencial Universitària de Manresa - Centre Penitenciari Lledoners
Manresa, Catalonia, Spain Recruiting -
Universidad de Zaragoza
Teruel, Teruel, Spain Not yet recruiting
Study contacts
- Study coordinator: Óscar Peris Baquero, Phd
- Email: operis@unizar.es
- Phone: 978645386
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Online treatment for emotional disorders in adults with long COVID-19
This study is testing if an online treatment for emotional issues can help adults with long COVID-19 feel better compared to regular care.
-
Long-term psychotropic medication effects on eye movements measured with the Gaize VR headset
This project will test whether the Gaize VR headset can detect eye-movement patterns associated with long-term use of prescribed psychotropic medications in adults.
-
Teen Recovery: Inspiration, Support, and Empowerment program
This pilot will test whether an online peer-led recovery and support program helps 15–18-year-olds recently discharged from psychiatric care reduce suicidal thoughts, depression, anxiety, and re-hospitalization.
-
Teleo virtual therapy for kids: testing engagement and outcomes in clinical care
We’re testing whether Teleo, a kid-focused virtual therapy platform, keeps young patients more engaged and improves anxiety and mood symptoms compared with standard video calls.
-
CONNECT program: group telehealth to reduce loneliness and improve mental health in adults 55+
This project will test whether the group-based CONNECT telehealth program can reduce loneliness, social isolation, anxiety, and depression in adults 55 and older compared with routine community programming.
-
Recovery Through Inspiration, Support, and Empowerment for Young Adults
This pilot will try peer-led one-on-one and small-group recovery support for 18–27-year-olds recently discharged from acute psychiatric care to help reduce suicidal thoughts, depression, anxiety, and rehospitalizations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.